1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Texas >
  6. Tissue Regenix Group Acquires CellRight Technologies

M&A Deal Summary

Tissue Regenix Group Acquires CellRight Technologies

On May 19, 2017, Tissue Regenix Group acquired life science company CellRight Technologies

Acquisition Highlights
  • This is Tissue Regenix Group’s 1st transaction in the Life Science sector.
  • This is Tissue Regenix Group’s 1st transaction in the United States.
  • This is Tissue Regenix Group’s 1st transaction in Texas.

M&A Deal Summary
Date 2017-05-19
Target CellRight Technologies
Sector Life Science
Buyer(s) Tissue Regenix Group
Deal Type Add-on Acquisition

Target

CellRight Technologies

Universal City, Texas, United States
CellRight Technologies is a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease. CellRight's human osteobiologics may be used in spine, trauma, general orthopedic, foot & ankle, dental, and sports medicine surgical procedures.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tissue Regenix Group

Garforth, United Kingdom
Category Company
Founded 2006
Sector Life Science
Employees78
Revenue 29M GBP (2024)
DESCRIPTION

Tissue Regenix was established to develop clinical solutions to address the chronic shortfalls in donor tissue availability in areas such as vascular and orthopeadic medicine. Tissue Regenix Group was founded in 2006 and is based in Garforth, United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2017 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal